Neurology

Your Article Summary

See Latest Articles

Protective actions of sex steroid hormones in Alzheimer's disease
Frontiers in Neuroendocrinology, 06/24/09

Pike CJ et al. – A review of the protective actions of sex steroid hormones in Alzheimer’s disease (AD) reports that the successful use of hormone therapies in aging men and women to delay, prevent, and or treat AD is pending research to optimize key parameters of hormone therapy and development of selective estrogen- and androgen-receptor modulators.

• Review of the protective actions of sex steroid hormones in AD

• Etrogens and progestogens depletion hypothesized to increase susceptibility to AD pathogenesis -- supported by epidemiologic evidence but refuted by some clinical findings
• Experimental evidence for neuroprotective actions of estrogen for AD prevention: promotion of neuron viability and reduction of beta-amyloid accumulation
• Diminished neural responsiveness to estrogen with age and reduced neuroprotective actions of estrogen limit use of hormone therapies in aged women
• Modulation of estrogen neuroprotective actions by progestogens
• Continuous progestogen exposure associated with inhibition of estrogen actions vs cyclic delivery of progestogens that enhances estrogen neural benefits
• Normal age-related testosterone loss in men associated with increased risk for AD
• Testosterone as an endogenous neuroprotective factor increases neuronal resilience and reduces beta-amyloid accumulation
• Androgen neuroprotective effects mediated both directly by androgen pathway activation and indirectly by aromatization to estradiol and initiation of protective estrogen signaling mechanisms

Today in Dementia...keeping you current

Receive free subspecialty "5-minute updates" via email

The Clinical Course of Advanced Dementia
New England Journal of Medicine, 10/16/09

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
European Journal of Neurology, 11/02/09

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
Clinical Interventions in Aging, 09/29/09

See All of Dementia

Today in Neuroendocrinology...keeping you current

Receive free subspecialty "5-minute updates" via email

Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09

The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09

Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09

See All of Neuroendocrinology